Mifepristone
Hundreds of industry leaders voiced support for the FDA after a judge ruled to invalidate the drug mifepristone's approval by the agency.
The former vice president is the first possible Republican presidential contender to applaud the controversial development.
A Health and Human Services official said it would "set a dangerous precedent for the Administration to disregard a binding decision."
More than a dozen Democratic governors urged seven major U.S. pharmacies not to bow to political pressure on medication abortion.
WHAT'S HAPPENING
A right-wing effort to pull FDA approval of mifepristone would have immediate and devastating consequences.
Many people across the country will be able to access abortion pills through a pharmacy or by mail, which could revolutionize access to care.
After decades of strict regulations, the FDA has an opportunity to make medication abortion easier to obtain just when reproductive rights are in serious peril.
Twenty years after medication abortion was approved in the U.S., patients are still jumping through hoops to access it.
In a victory for reproductive rights, many patients seeking medication abortion will no longer have to travel during the pandemic for care.
“People who need an abortion cannot delay care and should not needlessly risk coronavirus exposure,” the senators wrote to the Food and Drug Administration.